Skip to main content
Premium Trial:

Request an Annual Quote

Inverness Bid to Buy Biosite Passes Federal Waiting Period

NEW YORK (GenomeWeb News) — Inverness Medical Innovations today said that the required waiting period has expired on its proposed offer to buy Biosite without the need for additional information.
 
The company said on May 18 it would acquire Biosite for $92.50 share after a protracted bidding war with Beckman Coulter ended in its favor.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.